Clostridioides difficile infection: antimicrobial prescribing

2024 exceptional surveillance of clostridioides difficile infection: antimicrobial prescribing (NICE guideline NG199)

In July 2024, we reviewed the NICE guideline on Clostridioides difficile infection: antimicrobial prescribing in response to the new marketing authorisation for extended pulse dosing with fidaxomicin.

Surveillance decision

We will update the guideline to reflect this change.